Persistent Varicella Transmission in a High-Coverage Single-Dose Vaccination Program: Costa Rica, 2015-2024.
4 affiliations
- 1Department of Pediatrics, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense de Seguro Social (CCSS), San Jose 10101, Costa Rica.
- 2Department of Pediatric Infectious Diseases, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense de Seguro Social (CCSS), San Jose 10101, Costa Rica.
- 3Faculty of Medicine, Universidad de Ciencias Médicas (UCIMED), San Jose 10101, Costa Rica.
- 4Center for Infectious Disease Modeling and Analysis, Yale University School of Public Health, New Haven, CT 06520, USA.
Abstract
Background: Costa Rica introduced universal one-dose varicella vaccination in 2007 using a one-dose schedule administered at 15 months of age through the Costa Rican Social Security Fund (CCSS). A previous national study described epidemiological changes through 2014 by comparing pre- and post-vaccination periods; however, contemporary data on subsequent patterns and residual disease burden are limited. We characterized varicella epidemiology and healthcare burden in Costa Rica using the most recent nationally available data. Methods: We conducted a nationwide retrospective descriptive study using aggregated surveillance and administrative data. Outcomes included incidence of reported varicella cases (2015-2022), outpatient and emergency department visits (2019-2024), hospitalizations (2015-2024), in-hospital deaths with a recorded varicella diagnosis (2018-2020), institutional outbreaks, and first-dose vaccination coverage (2018-2024). Results: From 2015 to 2022, reported incidence declined by 84% in males and 83% in females, after increasing through 2019 and declining markedly during the COVID-19 pandemic. Children aged 1-9 years accounted for the largest proportion of reported cases. Among 354 hospitalizations, adults aged 20-44 years accounted for 30.5%. Hospitalizations among children aged ≤4 years decreased by approximately 56% between 2015-2018 and 2021-2024, while annual hospitalizations among adults aged 20-44 years increased from 7 in 2015 to 21 in 2024, representing a 200% increase over the study period. Three deaths occurred during hospitalizations with a varicella diagnosis, all among adults, and one institutional outbreak was identified. First-dose vaccination coverage averaged approximately 94% during 2018-2022 and remained high thereafter. Conclusions: Reported varicella incidence declined substantially during the study period, but circulation and healthcare burden persisted, with hospitalizations increasingly concentrated among adults. Because our analysis lacks a pre-vaccination comparator, these trends cannot be causally attributed to vaccination based on our data alone. The findings support maintaining high first-dose coverage and strengthening surveillance. Further information on individual vaccination history and population susceptibility is needed to evaluate the potential contribution of a two-dose vaccination strategy in Costa Rica.
Related
- Association Between Vaccination Awareness Program Exposure and Full Immunization Coverage Among Mothers in Rural Bangladesh: A Comparative Cross-Sectional Study in Jashore District.
- Hepatitis B vaccination coverage and factors associated with higher uptake among children aged 5–35 months in eight selected sub-Saharan African countries: a multilevel ordinal logistic regression analysis
- HPV vaccination coverage and barriers for people with disability: A scoping review.
- Assessing the impact of a gender-neutral approach to HPV vaccination on vaccination coverage for nine-year-old girls in Cameroon: A retrospective, cross-sectional study
- Adult Community-Acquired Pneumonia in the United States: The Economic Burden and the Potential Gains From Higher Vaccination Coverage
BibTeX
@article{hidalgomora2026persistent,
title = {{Persistent Varicella Transmission in a High-Coverage Single-Dose Vaccination Program: Costa Rica, 2015-2024.}},
author = {Oscar Hidalgo-Mora and Helena Brenes-Chacón and Sebastián Ospina-Henao and Alejandra Soriano-Fallas and Gabriela Naranjo-Zúñiga and Gabriela Ivankovich-Escoto and María L Ávila-Agüero},
journal = {Vaccines},
year = {2026},
month = oct,
doi = {10.3390/vaccines14100909},
url = {https://europepmc.org/article/MED/42931438},
note = {CC BY},
}
RIS
TY - JOUR
TI - Persistent Varicella Transmission in a High-Coverage Single-Dose Vaccination Program: Costa Rica, 2015-2024.
AU - Oscar Hidalgo-Mora
AU - Helena Brenes-Chacón
AU - Sebastián Ospina-Henao
AU - Alejandra Soriano-Fallas
AU - Gabriela Naranjo-Zúñiga
AU - Gabriela Ivankovich-Escoto
AU - María L Ávila-Agüero
PY - 2026
DA - 2026/10/19
JO - Vaccines
DO - 10.3390/vaccines14100909
UR - https://europepmc.org/article/MED/42931438
AB - Background: Costa Rica introduced universal one-dose varicella vaccination in 2007 using a one-dose schedule administered at 15 months of age through the Costa Rican Social Security Fund (CCSS). A previous national study described epidemiological changes through 2014 by comparing pre- and post-vaccination periods; however, contemporary data on subsequent patterns and residual disease burden are limited. We characterized varicella epidemiology and healthcare burden in Costa Rica using the most recent nationally available data. Methods: We conducted a nationwide retrospective descriptive study using aggregated surveillance and administrative data. Outcomes included incidence of reported varicella cases (2015-2022), outpatient and emergency department visits (2019-2024), hospitalizations (2015-2024), in-hospital deaths with a recorded varicella diagnosis (2018-2020), institutional outbreaks, and first-dose vaccination coverage (2018-2024). Results: From 2015 to 2022, reported incidence declined by 84% in males and 83% in females, after increasing through 2019 and declining markedly during the COVID-19 pandemic. Children aged 1-9 years accounted for the largest proportion of reported cases. Among 354 hospitalizations, adults aged 20-44 years accounted for 30.5%. Hospitalizations among children aged ≤4 years decreased by approximately 56% between 2015-2018 and 2021-2024, while annual hospitalizations among adults aged 20-44 years increased from 7 in 2015 to 21 in 2024, representing a 200% increase over the study period. Three deaths occurred during hospitalizations with a varicella diagnosis, all among adults, and one institutional outbreak was identified. First-dose vaccination coverage averaged approximately 94% during 2018-2022 and remained high thereafter. Conclusions: Reported varicella incidence declined substantially during the study period, but circulation and healthcare burden persisted, with hospitalizations increasingly concentrated among adults. Because our analysis lacks a pre-vaccination comparator, these trends cannot be causally attributed to vaccination based on our data alone. The findings support maintaining high first-dose coverage and strengthening surveillance. Further information on individual vaccination history and population susceptibility is needed to evaluate the potential contribution of a two-dose vaccination strategy in Costa Rica.
SN - 2076-393X
ER -